Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cancer news

Show

From To
HIV may increase the risk of skin cancer

People living with HIV may have an increased risk of some types of skin cancer, Danish researchers report in the online edition of the Journal

Published
09 May 2018
By
Michael Carter
Prostate cancer and lung cancer projected to be most frequent cancer diagnoses in people with HIV by 2030

Prostate and lung cancer will become the most frequently diagnosed cancers in people living with HIV in the United States by 2030 if current trends

Published
08 May 2018
By
Keith Alcorn
Increased Risk for Skin Cancer Among HIV-Infected Individuals

Patients with HIV infection have an increased risk for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), according to the results of a prospective, matched, nationwide, population-based Danish HIV cohort study published in the Journal of the American Academy of Dermatology.

Published
30 April 2018
From
Dermatology Advisor
Increased Mortality Among Lung Cancer Patients with HIV

Many studies have demonstrated that patients living with HIV are at a higher risk of a number of different types of malignancies, including lung cancer. Research has also shown that cancer patients living with HIV have a poorer prognosis than cancer patients who do not have HIV.

Published
25 April 2018
From
MD Magazine
What are the outcomes for adults who were born with HIV?

Among people who were born with HIV and have now transitioned to adult care at St Mary’s hospital in London, 80% have an undetectable viral load,

Published
25 April 2018
By
Roger Pebody
HIV-Associated Cancers: A Paradigm Shift?

An increasing number of patients with HIV now live long enough to get the “incidental” cancers seen in the general population. Yet these patients are also less likely to get the 3 cancers that once defined AIDS — Kaposi sarcoma, aggressive B-cell lymphoma, and invasive cervical cancer — which were frequently seen when the disease was first observed.

Published
23 April 2018
From
Cancer Therapy Advisor
HPV vaccine lacks efficacy in adults with HIV

Results of a phase 3 trial recently published in Clinical Infectious Diseases showed that the quadrivalent HPV vaccine was not effective in preventing new anal infections or improving high-grade squamous intraepithelial lesions in adults aged 27 years or older with HIV.

Published
23 April 2018
From
Healio
Researchers puzzle over whether HIV accelerates cancer progression

Although people living with HIV may be diagnosed with cancer at an earlier stage because they get more consistent care than the general population, it

Published
16 April 2018
By
Liz Highleyman
Lymphoma incidence 15 times higher in HIV/HCV coinfection

Lymphoma incidence 15 times higher in HIV/HCV coinfectionHealioThe incidence of lymphoma — Hodgkin and non-Hodgkin — was up to 15 times higher among patients with HIV monoinfection and HIV/hepatitis C virus coinfection compared with the general population, according to findings presented at the International Liver Congress.

Published
16 April 2018
From
Healio
Call to extend HPV vaccine to boys as cancer rates soar

NHS England urged to act after new figures reveal rising head and neck tumours in men: Health officials will soon come under increasing pressure to extend vaccination against the cancer-causing human papilloma virus to young men. Doctors say new figures, to be released in a few weeks, will show that rates of head and neck cancers in men are now rising so quickly that it is imperative the policy is reversed. “To be blunt, the case for giving the vaccine to boys as well as girls is now unequivocal as far as I am concerned,” said Professor Mark Lawler, of Queen’s University Belfast. “We have a chance to eradicate both these conditions – cervical as well as neck and head cancers – and we should not be hesitating.”

Published
01 April 2018
From
The Guardian
← First12345...49Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.